Home
Conditions
Lymphoma, B-Cell

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

1,618 public trials 340 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Completed

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

NCT00054327

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +51 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Efficacy , Safety of Treatment R NIMP for Relapsed Aggressive Lymphomas

NCT00842595

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Hôpital COCHIN Paris, France

View Trial Details

Completed

VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative Disorders

NCT00304005

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +18 more
Locations: M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States

View Trial Details

Completed

VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas

NCT00025129

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
Locations: Arizona Clinical Research Center Tucson, Arizona, United States

Yale Comprehensive Cancer Center New Haven, Connecticut, United States

Veterans Affairs Medical Center - West Haven West Haven, Connecticut, United States

View Trial Details

Completed

Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors

NCT00002543

Conditions: Brain and Central Nervous System Tumors, Burkitt Lymphoma, Central Nervous System Neoplasms, +33 more
Locations: Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States

Boston Floating Hospital Infants and Children Boston, Massachusetts, United States

Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Completed

Rituximab and Interleukin-2 in Treating Patients With Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma

NCT00059904

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

VNP40101M in Treating Patients With Advanced or Metastatic Cancer

NCT00049699

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
Locations: Yale Comprehensive Cancer Center New Haven, Connecticut, United States

Veterans Affairs Medical Center - West Haven West Haven, Connecticut, United States

Ireland Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma

NCT00562380

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +57 more
Locations: Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

NCT00062296

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
Locations: Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma

NCT00005021

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
Locations: Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Lymphoma, B-Cell

Lymphoma, B-Cell trial results

Related conditions